Axsome Therapeutics, Inc. (AXSM) NASDAQ

131.60

+3.66(+2.86%)

Updated at October 20 04:00PM

Currency In USD

Valuation

Market Cap4.05B
Enterprise Value3.93B
P/E Ratio-26.35
PEG Ratio-2.17
Price/Sales Ratio13.27
Price/Book Ratio89.04
Enterprise/Revenue13.09
Enterprise/EBITDA-28.82

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.5
Operating Margin-0.46

Management Effectiveness

Return On Assets-0.39
Return On Equity-3.58

Income Statement

Revenue385.69M
Revenue/Share10.01
Gross Profit352.39M
EBITDA-272.6M
Net Income-287.22M
Diluted EPS-5.99

Balance Sheet

Total Cash303.02M
Total Cash/Share6.13
Total Debt215.29M
Total Debt/Equity2.95
Current Ratio1.57
Book Value Per Share1.48

Price History

52-Week Change43.83
52-Week High139.13
52-Week Low75.56
Moving Average 50 Days118.6
Moving Average 200 Days111.41

Statistics

Average Volume559,550
Shares Outstanding49.9M
% Held by Institutions74.32

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A